BioCentury | May 17, 2019
Product Development

Abeona tackles gene therapy’s problems in cystic fibrosis with chimeric AAVs

...respond to inquiries about its status. Copernicus Therapeutics Inc. ran a Phase I/II trial of CFx...
BioCentury | Dec 17, 2007
Company News

Copernicus, Cystic Fibrosis Foundation deal

...CFTR) gene activity in an animal model. Copernicus' lead gene therapy to treat CF is CFx...
BioCentury | Feb 19, 2007
Company News

Copernicus, Cystic Fibrosis Foundation pulmonary, gene/cell therapy news

...arm of the foundation, to develop CFx non-viral gene therapy to treat cystic fibrosis (CF). CFx...
BioCentury | Dec 12, 2005
Tools & Techniques

Visualizing new partnerships

...to be used for 30 months in a clinical study alongside the company's Aquilion 64 CFX...
Items per page:
1 - 4 of 4